The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
15 Apr 2019
Historique:
received: 19 03 2019
accepted: 06 04 2019
entrez: 17 4 2019
pubmed: 17 4 2019
medline: 14 8 2019
Statut: epublish

Résumé

Integrating mobile phone-based health (m-health) interventions into healthcare systems is one solution to improve access to services for the growing number of patients with chronic illness. Practical challenges such as poor recruitment and inadequate resource allocation can hamper the assessment of such interventions with clinical trial methodology. This paper highlights the challenges encountered during a pilot randomized controlled trial of an m-health medication adherence intervention and offers recommendations for future multi-site, non-drug clinical trials. Eighteen patients were recruited to the study; eight were randomly allocated to the intervention arm. Intervention participants responded to their daily medication-reminder text messages, indicating that medication had been taken or not, and nurses were able to organize their calls around their workload. The trial closed prematurely primarily due to inadequate numbers of eligible patients; however, other potentially resolvable feasibility issues were identified. These included lack of infrastructure at study sites, poor screening data acquisition and management processes, and inexperience in conducting supportive care trials at participating sites. M-health intervention trials are designed to inform implementation of best supportive care practice. Adequate skills and infrastructure are research prerequisites that require careful consideration and sufficient investment for the successful execution of multi-site supportive care trials. Trial registration Australian and New Zealand Clinical Trials Register: ACTRN12612000635864.

Identifiants

pubmed: 30987685
doi: 10.1186/s13104-019-4264-6
pii: 10.1186/s13104-019-4264-6
pmc: PMC6466650
doi:

Substances chimiques

Antineoplastic Agents 0

Banques de données

ANZCTR
['ACTRN12612000635864']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Pagination

226

Subventions

Organisme : Australiasian Lymphoma and Leukaemia Group
ID : ALLG SC04

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Educ Health (Abingdon). 2003 Jul;16(2):230
pubmed: 14741909
Trials. 2017 Aug 1;18(1):360
pubmed: 28764809
Clin Trials. 2012 Apr;9(2):257-64
pubmed: 22064687
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011
pubmed: 18425859
Acta Oncol. 2015 May;54(5):805-12
pubmed: 25813474
BMJ. 2016 Feb 17;352:i637
pubmed: 26888209
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1665-73
pubmed: 18628418
J Am Med Inform Assoc. 2015 Apr;22(e1):e177-93
pubmed: 25726568
JMIR Mhealth Uhealth. 2017 Dec 06;5(12):e184
pubmed: 29212628
Ann Intern Med. 2008 Feb 19;148(4):295-309
pubmed: 18283207
Br J Clin Pharmacol. 2011 Mar;71(3):467-70
pubmed: 21284707
Am J Public Health. 2003 Aug;93(8):1261-7
pubmed: 12893608
J Clin Epidemiol. 2007 Aug;60(8):819-24
pubmed: 17606178
Support Care Cancer. 2003 Dec;11(12):775-9
pubmed: 14564494
J Clin Transl Sci. 2017 Jan 13;1(1):8-15
pubmed: 31660210
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
J Med Internet Res. 2018 Nov 29;20(11):e11050
pubmed: 30497997
J Clin Oncol. 2009 Dec 10;27(35):6041-51
pubmed: 19884523
JAMA. 2016 Oct 4;316(13):1353-1354
pubmed: 27636028
Biomed Res Int. 2015;2015:217047
pubmed: 26539470

Auteurs

Lahiru Russell (L)

School of Nursing and Midwifery, Faculty of Health, Deakin University, Geelong, VIC, Australia.

Michaela C Pascoe (MC)

Institute of Sport, Exercise and Active Living, Victoria University, Footscray, VIC, Australia.

John F Seymour (JF)

Peter MacCallum Cancer Centre, Parkville, Melbourne, VIC, Australia.
Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia.
University of Melbourne, Melbourne, VIC, Australia.

Sanchia Aranda (S)

University of Melbourne, Melbourne, VIC, Australia.
Cancer Council Australia, Sydney, Australia.

Phyllis Butow (P)

Department of Psychology, University of Sydney, Sydney, Australia.

Karla Gough (K)

Peter MacCallum Cancer Centre, Parkville, Melbourne, VIC, Australia.
University of Melbourne, Melbourne, VIC, Australia.

Penelope Schofield (P)

Peter MacCallum Cancer Centre, Parkville, Melbourne, VIC, Australia. pschofield@swin.edu.au.
University of Melbourne, Melbourne, VIC, Australia. pschofield@swin.edu.au.
Swinburne University of Technology, Hawthorn, VIC, Australia. pschofield@swin.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH